Skip to content

Screener

Eligibility screening

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Soli…

Sponsored by Shanghai Henlius BiotechStudy detailsClinicalTrials.gov

12 US sites in CA, FL, TX, WA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.